Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Curcumin and Ursolic Acid in Healthy Men
NCT04421716Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2020
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by UT Health San Antonio. Primary endpoints: Number, frequency, duration, and relation of toxicity events at 2 weeks, Peak serum concentration at 2 weeks and 2 more. Started Oct 2020; status: completed.
Beyond the preview
Go deeper on NCT04421716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04421716.